ATV concentrations in plasma, lymph nodes, liver and spleen.
Figures are generally photos, graphs and static images that would be represented in traditional pdf publications.
Following intraperitoneal injection of nanoATV, plasma, mesenteric lymph nodes, liver and spleen were collected 1, 4, 12, 24, 48, and 72 h post injection. ATV concentrations were determined by UPLC-MS/MS. Tissue drug levels are reported as mean ± SEM for 4–8 mice/time point.